Commission Delegated Regulation (EU) 2025/1475 of 21 May 2025 amending Regulation (EC) No 273/2004 of the European Parliament and of the Council and Council Regulation (EC) No 111/2005 as regards the inclusion of the drug precursors 4-piperidone and 1-boc-4-piperidone in the list of scheduled substances

• CELEX: Delegated Regulation (EU) 2025/1475
• Articles: 5

Article 1 Amendments to Regulation (EC) No 273/2004

Annex I to Regulation (EC) No 273/2004 is amended in accordance with Annex I to this Regulation.

Article 2 Amendments to Regulation (EC) No 111/2005

The Annex to Regulation (EC) No 111/2005 is amended in accordance with Annex II to this Regulation.

Article 3 Entry into force

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX I

ANNEX I

In Annex I to Regulation (EC) No 273/2004, in the table for Category 1, the following entries are inserted in the list of substances in the appropriate place sequentially according to the CN Code:

Substance

CN designation (if different)

CN Code

CAS No

‘4-piperidone

Piperidin-4-one

2933 39 99

41661-47-6’

‘1-boc-4-piperidone

tert-butyl 4-oxopiperidine-1-carboxylate

2933 39 99

79099-07-3.’

ANNEX II

ANNEX II

In the Annex to Regulation (EC) No 111/2005, in the table for Category 1, the following entries are inserted in the list of substances in the appropriate place sequentially according to the CN Code:

Substance

CN designation (if different)

CN Code

CAS No

‘4-piperidone

Piperidin-4-one

2933 39 99

41661-47-6’

‘1-boc-4-piperidone

tert-butyl 4-oxopiperidine-1-carboxylate

2933 39 99

79099-07-3’